* correspondent respectivement à un seuil de significativité p<0, pp.0-01 ,
The organizing principle of the platelet glycoprotein Ib-IX-V complex, Journal of Thrombosis and Haemostasis, vol.106, issue.4, pp.605-619, 2013. ,
DOI : 10.1182/blood-2005-01-0440
Coagulation 2006: A Modern View of Hemostasis, Hematology/Oncology Clinics of North America, vol.21, issue.1, pp.1-11, 2007. ,
DOI : 10.1016/j.hoc.2006.11.004
Déficit en facteur XI, Hemotologie, vol.16, pp.284-92, 2010. ,
Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII, Biochemistry, vol.30, issue.45, pp.10819-10843, 1991. ,
DOI : 10.1021/bi00109a001
Studies on the basis for the properties of fibrin produced from fibrinogen-containing ?' chains, Blood, vol.106, issue.8, pp.2730-2736, 2005. ,
DOI : 10.1182/blood-2005-01-0240
The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitasking, Journal of Thrombosis and Haemostasis, vol.4, issue.Suppl., pp.1097-105, 2007. ,
DOI : 10.1161/01.ATV.20.3.874
Plasmin as a proinflammatory cell activator, Journal of Leukocyte Biology, vol.92, issue.3, pp.509-528, 2012. ,
DOI : 10.1189/jlb.0212056
Thrombin activatable fibrinolysis inhibitor (TAFI)?How does thrombin regulate fibrinolysis?, Annals of Medicine, vol.41, issue.255, pp.378-88, 2006. ,
DOI : 10.1053/j.seminhematol.2003.11.004
Cost-of-illness model for venous thromboembolism, Thrombosis Research, vol.145, p.2016 ,
DOI : 10.1016/j.thromres.2016.06.022
Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study, BMJ, vol.343, issue.aug16 1, pp.46-56, 2011. ,
DOI : 10.1136/bmj.d4656
Pulmonary Embolism: What have We Learned Since Virchow?, Chest, vol.122, issue.4, pp.1440-56, 2002. ,
DOI : 10.1378/chest.122.4.1440
Incidence and mortality of venous thrombosis: a population-based study, Journal of Thrombosis and Haemostasis, vol.34, issue.4, pp.692-701, 2007. ,
DOI : 10.1056/NEJM200012213432504
Triggers of Hospitalization for Venous Thromboembolism, Circulation, vol.125, issue.17, pp.2092-2101, 2012. ,
DOI : 10.1161/CIRCULATIONAHA.111.084467
Assessing Risk of Venous Thromboembolism in the Patient With Cancer, Journal of Clinical Oncology, vol.27, issue.29, pp.4839-4886, 2009. ,
DOI : 10.1200/JCO.2009.22.3271
The Role of Thrombophilia in Pregnancy, Thrombosis, vol.100, issue.3, p.516420, 2013. ,
DOI : 10.1016/S0002-9378(96)70610-5
Epidemiology and Risk Factors for Venous Thrombosis, Seminars in Hematology, vol.44, issue.2, pp.62-71, 2007. ,
DOI : 10.1053/j.seminhematol.2007.02.004
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020806
Inherited antithrombin deficiency causig thrombophilia. Thromb diat hemorra, pp.516-546, 1965. ,
The phenotypic and genetic assessment of antithrombin deficiency, International Journal of Laboratory Hematology, vol.12, issue.3, pp.227-264, 2011. ,
DOI : 10.1097/00001721-200106000-00002
Hemizygous antithrombin-deficiency (Budapest III) in a newborn presenting with a thrombosis at birth, British Journal of Haematology, vol.76, issue.3, pp.397-405, 2007. ,
DOI : 10.1016/0014-5793(92)80854-A
Deficiency of protein C in congenital thrombotic disease., Journal of Clinical Investigation, vol.68, issue.5, pp.1370-1373, 1981. ,
DOI : 10.1172/JCI110385
Polymorphisms in the endothelial protein C receptor gene and thrombophilia, Thrombosis and Haemostasis, vol.98, pp.564-573, 2007. ,
DOI : 10.1160/TH07-01-0071
Familial protein S deficiency is associated with recurrent thrombosis., Journal of Clinical Investigation, vol.74, issue.6, pp.2082-2090, 1984. ,
DOI : 10.1172/JCI111632
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC425398
Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature, vol.369, issue.6475, pp.64-71, 1994. ,
DOI : 10.1038/369064a0
A common genetic variation in the 3'untranslated region of prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis, Blood, vol.88, pp.3698-703, 1996. ,
Classic thrombophilic gene variants, Thrombosis and Haemostasis, vol.114, issue.5, pp.885-894, 2015. ,
DOI : 10.1160/TH15-02-0141
The Antiphospholipid Syndrome, New England Journal of Medicine, vol.346, issue.10, pp.752-63, 2002. ,
DOI : 10.1056/NEJMra002974
ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS, The Lancet, vol.322, issue.8361, pp.1211-1215, 1983. ,
DOI : 10.1016/S0140-6736(83)91267-9
A Phospholipid-?2-Glycoprotein I Complex Is an Antigen for Anticardiolipin Antibodies Occurring in Autoimmune Disease But Not with Infection, Lupus, vol.884, issue.1, pp.75-81, 1992. ,
DOI : 10.1016/0304-4165(86)90237-0
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), Journal of Thrombosis and Haemostasis, vol.75, issue.2, pp.295-306, 2006. ,
DOI : 10.1093/ajcp/103.1.103
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients, Arthritis & Rheumatism, vol.15, issue.suppl 7, pp.1019-1046, 2002. ,
DOI : 10.1006/jaut.2000.0423
Epidemiology of the Antiphospholipid Antibody Syndrome, Journal of Autoimmunity, vol.15, issue.2, pp.145-51, 2000. ,
DOI : 10.1006/jaut.2000.0409
Familial lupus and antiphospholipid syndrome Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature, Lupus. Blood, vol.16101, pp.556-563, 2003. ,
Seronegative antiphospholipid syndrome, Rheumatology, vol.52, issue.8, pp.1358-67, 2013. ,
DOI : 10.1093/rheumatology/ket126
The antiphospholipid syndrome: from pathophysiology to treatment, Clinical and Experimental Medicine, vol.2, issue.9, 2016. ,
DOI : 10.1111/j.1538-7836.2004.00904.x
The Pathogenesis of the Antiphospholipid Syndrome, New England Journal of Medicine, vol.368, issue.11, pp.1033-1077, 2013. ,
DOI : 10.1056/NEJMra1112830
Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study-NOHA, Thromb Haemost, vol.84, pp.228-264, 2000. ,
Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome, JAMA, vol.302, issue.11, pp.1210-1217, 2009. ,
DOI : 10.1001/jama.2009.1346
The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome, Thromb Haemost, vol.79, pp.276-81, 1998. ,
Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis, Thrombosis and Haemostasis, vol.92, pp.1312-1321, 2004. ,
DOI : 10.1160/TH04-03-0138
Complement activation in anti-phospholipid syndrome: A clue for an inflammatory process?, Journal of Autoimmunity, vol.28, issue.2-3, pp.160-164, 2007. ,
DOI : 10.1016/j.jaut.2007.02.013
Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: A systematic review and meta-analysis, Autoimmunity Reviews, vol.13, issue.6, pp.595-608, 2014. ,
DOI : 10.1016/j.autrev.2013.11.004
Facteurs de risque de r?cidive de la maladie thromboembolique veineuse, Revue des Maladies Respiratoires, vol.28, issue.4, pp.453-462, 2011. ,
DOI : 10.1016/j.rmr.2010.10.036
Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy, The American Journal of Medicine, vol.104, issue.4, pp.332-340, 1998. ,
DOI : 10.1016/S0002-9343(98)00060-6
Recurrent Thrombosis in Patients with Deep Vein Thrombosis and/or Venous Thromboembolism Associated with Anticardiolipin Antibodies, Angiology, vol.57, issue.1, pp.79-83, 2006. ,
DOI : 10.1177/000331970605700111
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study, Blood, vol.118, issue.17, pp.4714-4722, 2011. ,
DOI : 10.1182/blood-2011-03-340232
Review: antiphospholipid antibodies and the lung, J Rheumatol, vol.22, pp.62-68, 1995. ,
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients, Annals of the Rheumatic Diseases, vol.82, issue.(Suppl 7), pp.1011-1019, 2015. ,
DOI : 10.1097/01.md.0000091181.93122.55
Pulmonary manifestations in antiphospholipid syndrome, Autoimmunity Reviews, vol.5, issue.5, pp.344-352, 2006. ,
DOI : 10.1016/j.autrev.2006.02.002
Inherited thrombophilia in women with poor aPL-related obstetric history: prevalence and outcomes. Survey of 208?cases from the European Registry on Obstetric Antiphospholipid Syndrome cohort, American Journal of Reproductive Immunology, vol.112, issue.abst suppl, pp.164-71, 2016. ,
DOI : 10.1160/TH14-03-0191
Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies, American Journal of Obstetrics and Gynecology, vol.196, issue.2, p.167, 2007. ,
DOI : 10.1016/j.ajog.2006.10.879
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies, Arthritis & Rheumatism, vol.114, issue.Suppl, pp.2311-2318, 2012. ,
DOI : 10.1016/j.thromres.2004.08.006
Antiphospholipid Antibodies in Stillbirth, Obstetrics & Gynecology, vol.122, issue.3, pp.641-57, 2013. ,
DOI : 10.1097/AOG.0b013e3182a1060e
Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss*, Journal of Obstetrics and Gynaecology Research, vol.267, issue.2, pp.326-358, 2004. ,
DOI : 10.1046/j.1538-7836.2003.00022.x
Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis?, J Rheumatol, vol.33, pp.1038-1082, 2006. ,
Sneddon?s syndrome: a comprehensive review of the literature, Orphanet Journal of Rare Diseases, vol.30, issue.1, p.215, 2014. ,
DOI : 10.1007/s00296-009-1093-2
Catastrophic antiphospholipid syndrome: a clinical review, J Nephropathol, vol.3, pp.9-17, 2014. ,
Laboratory studies on pathophysiology of the catastrophic antiphospholipid syndrome, Autoimmunity Reviews, vol.6, issue.2, pp.68-71, 2006. ,
DOI : 10.1016/j.autrev.2006.06.006
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop, Arthritis & Rheumatism, vol.7, issue.7, pp.1309-1320, 1999. ,
DOI : 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity, Thrombosis and Haemostasis, vol.112, issue.4, pp.727-762, 2014. ,
DOI : 10.1160/TH14-03-0191
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines, Lupus, vol.42, issue.7, pp.530-534, 2003. ,
DOI : 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
Recent Guidelines and Recommendations for Laboratory Detection of Lupus Anticoagulants, Seminars in Thrombosis and Hemostasis, vol.40, issue.02, pp.163-71, 2014. ,
DOI : 10.1055/s-0033-1364185
La recherche des facteurs biologiques de risque établis de maladie thromboembolique veineuse: état des connaissances et conséquences pour la pratique en biologie clinique, Sang Thromb Vaiss, vol.21, pp.12-39, 2009. ,
DOI : 10.1016/j.jmv.2008.12.102
Recherche complémentaire et identification d'un anticoagulant lupique. Saint-Denis La Plaine: HAS, 2006. ,
Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort, Thrombosis and Haemostasis, vol.102, pp.25-28, 2009. ,
DOI : 10.1160/TH09-01-0043
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: A randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody?positive individuals, Arthritis & Rheumatism, vol.113, issue.7, pp.2382-91, 2007. ,
DOI : 10.1136/bmj.309.6963.1215
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies, Lupus, vol.7, issue.2, p.206, 2011. ,
DOI : 10.1111/j.1538-7836.2009.03588.x
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)1, Journal of Thrombosis and Haemostasis, vol.68, issue.5, pp.848-53, 2005. ,
DOI : 10.1001/jama.291.5.576
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome, New England Journal of Medicine, vol.349, issue.12, pp.1133-1141, 2003. ,
DOI : 10.1056/NEJMoa035241
GAPSS: the Global Anti-Phospholipid Syndrome Score, Rheumatology, vol.52, issue.8, pp.1397-403, 2013. ,
DOI : 10.1093/rheumatology/kes388
URL : http://doi.org/10.1093/rheumatology/kes388
Mode of action of hydroxychloroquine in RA?evidence of an inhibitory effect on toll-like receptor signaling, Nature Clinical Practice Rheumatology, vol.52, issue.9, pp.458-467, 2006. ,
DOI : 10.4049/jimmunol.168.10.5303
Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients, J Thromb Haemost, vol.11, pp.1927-1936, 2013. ,
Efficacy of prednisone treatment to prevent recurrent fetal death, American Journal of Obstetrics and Gynecology, vol.162, issue.4, pp.1128-1137, 1990. ,
DOI : 10.1016/0002-9378(90)91341-9
Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody, American Journal of Obstetrics and Gynecology, vol.160, issue.2, pp.439-443, 1989. ,
DOI : 10.1016/0002-9378(89)90468-7
Effectiveness of prednisolone/aspirin therapy for recurrent aborters with antiphospholipid antibody, Human Reproduction, vol.7, issue.2, pp.203-207, 1992. ,
DOI : 10.1093/oxfordjournals.humrep.a137617
Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment, American Journal of Obstetrics and Gynecology, vol.166, issue.5, pp.1318-1341, 1992. ,
DOI : 10.1016/0002-9378(92)91596-3
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study, Autoimmunity Reviews, vol.14, issue.6, pp.498-502, 2015. ,
DOI : 10.1016/j.autrev.2015.01.012
Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients, Arthritis & Rheumatism, vol.11, issue.8, pp.2568-76, 2006. ,
DOI : 10.1002/art.22018
The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome, Transfusion and Apheresis Science, vol.33, issue.1, pp.11-18, 2005. ,
DOI : 10.1016/j.transci.2004.10.025
Antiphospholipid Antibodies Attenuate Endothelial Repair and Promote Neointima Formation in Mice, Journal of the American Heart Association, vol.3, issue.5, p.1369, 2014. ,
DOI : 10.1161/JAHA.114.001369
Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?, Lupus, vol.41, issue.3, pp.185-94, 2008. ,
DOI : 10.1093/rheumatology/41.suppl_2.17
Infliximab improves endothelial dysfunction in a mouse model of antiphospholipid syndrome: Role of reduced oxidative stress, Vascular Pharmacology, vol.71, pp.93-101, 2015. ,
DOI : 10.1016/j.vph.2015.03.014
A thrombin generation test; the application in haemophilia and thrombocytopenia, J Clin Pathol, vol.6, pp.3-8, 1953. ,
Thrombin generation, a function test of the haemostatic-thrombotic system, Thromb Haemost, vol.96, pp.553-61, 2006. ,
Standardisation of thrombin generation test - which reference plasma for TGT?: An international multicentre study, Thrombosis Research, vol.125, issue.4, pp.353-359, 2010. ,
DOI : 10.1016/j.thromres.2009.11.012
Test de génération de thrombine: importance d'établir les valeurs de référence en fonction de l'âge et des concentrations en facteur tissulaire avant l'implémentation au laboratoire, pp.69-73 ,
Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram- Thrombinoscope assay, Thrombosis Journal, vol.3, issue.1, p.16, 2005. ,
DOI : 10.1186/1477-9560-3-16
Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Thrombin Generation, JAMA, vol.296, issue.4, pp.397-402, 2006. ,
DOI : 10.1001/jama.296.4.397
High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism, Journal of Thrombosis and Haemostasis, vol.2, issue.8, pp.1327-1360, 2008. ,
DOI : 10.1161/01.CIR.92.10.2800
High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study, Journal of Thrombosis and Haemostasis, vol.138, issue.10, pp.1720-1725, 2008. ,
DOI : 10.7326/0003-4819-125-1-199607010-00001
The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study: reply, Journal of Thrombosis and Haemostasis, vol.13, issue.12, pp.2286-2293, 2015. ,
DOI : 10.1111/jth.13170
Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence, British Journal of Haematology, vol.1, issue.6, pp.769-74, 2007. ,
DOI : 10.1111/j.1365-2141.2007.06738.x
Utility of Thrombin-Generation Assay in the Screening of Factor V G1691A (Leiden) and Prothrombin G20210A Mutations and Protein S Deficiency, Clinical Chemistry, vol.52, issue.4, pp.665-70, 2006. ,
DOI : 10.1373/clinchem.2005.063339
Protein S inherited qualitative deficiency: novel mutations and phenotypic influence, Journal of Thrombosis and Haemostasis, vol.8, issue.Suppl 1, pp.2718-2744, 2010. ,
DOI : 10.1111/j.1538-7836.2010.04073.x
URL : https://hal.archives-ouvertes.fr/inserm-01142383
Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants, Thromb Haemost, vol.89, pp.208-220, 2003. ,
Development of a calibrated automated thrombography based thrombin generation test in mouse plasma, Journal of Thrombosis and Haemostasis, vol.70, issue.10, pp.2079-86, 2007. ,
DOI : 10.1046/j.1365-2141.2003.04443.x
Whole blood thrombin generation in Bmal1-deficient mice, Thrombosis and Haemostasis, vol.112, issue.2, pp.271-276, 2014. ,
DOI : 10.1160/TH13-11-0910
Monitoring platelet dependent thrombin generation in mice, Thrombosis Research, vol.126, issue.5, pp.436-477, 2010. ,
DOI : 10.1016/j.thromres.2010.08.007
Hemostasis in the Mouse (Mus Musculus) : A Review, Thromb Hemost, vol.81, pp.177-88, 1999. ,
Circulating platelet-derivated microparticles in systemic lupus erythematosus. Association with thrombin generation and procoagulant state, Thromb Haemost, vol.95, pp.94-103, 2006. ,
Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInk?ping Study on Thrombosis (LIST) ? A 7-year follow-up, Thrombosis Research, vol.131, issue.2, pp.135-144, 2013. ,
DOI : 10.1016/j.thromres.2012.11.015